CANCER Calculated treatment

被引：63
作者：
Komarova, Natalia L. [1 ,2 ]
Boland, C. Richard [3 ]
机构：
[1] Univ Calif Irvine, Dept Math, Irvine, CA 92697 USA
[2] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA
[3] Baylor Univ, Med Ctr, Dept Gastroenterol, Dallas, TX 75246 USA
来源：
NATURE | 2013年 / 499卷 / 7458期
关键词：
RESISTANCE;
D O I：
10.1038/499291a
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
Mathematical modelling linked with patient data suggests that combination therapy is more effective than sequential treatment at preventing drug resistance in cancer. This predictive approach may pave the way for personalized therapies.
引用
收藏
页码：291 / 292
页数：2
相关论文
共 8 条
  • [1] Evolutionary dynamics of cancer in response to targeted combination therapy
    Bozic, Ivana
    Reiter, Johannes G.
    Allen, Benjamin
    Antal, Tibor
    Chatterjee, Krishnendu
    Shah, Preya
    Moon, Yo Sup
    Yaqubie, Amin
    Kelly, Nicole
    Le, Dung T.
    Lipson, Evan J.
    Chapman, Paul B.
    Diaz, Luis A., Jr.
    Vogelstein, Bert
    Nowak, Martin A.
    [J]. ELIFE, 2013, 2
  • [2] Comparison of imatinib, mesylate, dasatinib (BMS-354825), and nilotinib (AMN107) in an N-ethyl-N-nitrosourea (ENU)-based mutagenesis screen:: high efficacy of drug combinations
    Bradeen, Heather A.
    Eide, Christopher A.
    O'Hare, Thomas
    Johnson, Kara J.
    Willis, Stephanie G.
    Lee, Francis Y.
    Druker, Brian J.
    Deininger, Michael W.
    [J]. BLOOD, 2006, 108 (07) : 2332 - 2338
  • [3] The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
    Diaz, Luis A., Jr.
    Williams, Richard T.
    Wu, Jian
    Kinde, Isaac
    Hecht, J. Randolph
    Berlin, Jordan
    Allen, Benjamin
    Bozic, Ivana
    Reiter, Johannes G.
    Nowak, Martin A.
    Kinzler, Kenneth W.
    Oliner, Kelly S.
    Vogelstein, Bert
    [J]. NATURE, 2012, 486 (7404) : 537 - 540
  • [4] The Worst Drug Rule Revisited: Mathematical Modeling of Cyclic Cancer Treatments
    Katouli, Allen A.
    Komarova, Natalia L.
    [J]. BULLETIN OF MATHEMATICAL BIOLOGY, 2011, 73 (03) : 549 - 584
  • [5] Optimizing Combination Therapies with Existing and Future CML Drugs
    Katouli, Allen A.
    Komarova, Natalia L.
    [J]. PLOS ONE, 2010, 5 (08):
  • [6] Combination of Two but Not Three Current Targeted Drugs Can Improve Therapy of Chronic Myeloid Leukemia
    Komarova, Natalia L.
    Katouli, Allen A.
    Wodarz, Dominik
    [J]. PLOS ONE, 2009, 4 (02):
  • [7] Drug resistance in cancer: Principles of emergence and prevention
    Komarova, NL
    Wodarz, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (27) : 9714 - 9719
  • [8] Targeting cancer with small molecule kinase inhibitors
    Zhang, Jianming
    Yang, Priscilla L.
    Gray, Nathanael S.
    [J]. NATURE REVIEWS CANCER, 2009, 9 (01) : 28 - 39
1